Updated Jul 16, 2026
Capper Joseph H has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.

Joseph H. Capper is the Chief Executive Officer of MiMedx Group, Inc., a biotechnology company specializing in regenerative medicine and advanced wound care products. He has a background in business leadership and has held various executive roles in the healthcare sector. Under his leadership, MiMedx has focused on innovation and expanding its product offerings.
| Role | Insider |
|---|---|
| Notability | 70/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-23 | ANIK | Anika Therapeutics, Inc. | A — Grant or award | 10.4K | $0.00 | |
| 2026-06-11 | TELA | TELA Bio, Inc. | A — Grant or award | 11.7K | $0.00 | |
| 2026-06-11 | TELA | TELA Bio, Inc. | A — Grant or award | 11.9K | $0.00 | |
| 2026-03-06 | MDXG | MIMEDX GROUP, INC. | A — Grant or award | 371.1K | $0.00 |
Joseph H. Capper is the Chief Executive Officer of MiMedx Group, Inc., a biotechnology company specializing in regenerative medicine and advanced wound care products. He has a background in business leadership and has held various executive roles in the healthcare sector. Under his leadership, MiMedx has focused on innovation and expanding its product offerings.…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Capper Joseph H profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.